Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1
Authors:
- Petrea M. KellsPKPetrea M. Kells
- Paul R. Ortiz de MontellanoPMPaul R. Ortiz de Montellano
- Larissa M. PodustLPLarissa M. Podust
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (1) , 332-337
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Energy (DE-AC02-05CH11231)
- Office of Science
- Basic Energy Sciences
- National Institutes of Health (AI74824, GM078553, GM25515)
This publication has 47 references indexed in Scilit:
- Structural control of cytochrome P450-catalyzed ω-hydroxylationArchives of Biochemistry and Biophysics, 2011
- The Mycobacterium tuberculosis cytochrome P450 systemArchives of Biochemistry and Biophysics, 2010
- Biochemical and structural characterization of CYP124: A methyl-branched lipid ω-hydroxylase from Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2009
- Mycobacterial Cytochrome P450 125 (Cyp125) Catalyzes the Terminal Hydroxylation of C27 SteroidsJournal of Biological Chemistry, 2009
- The Structure of Mycobacterium tuberculosis CYP125Journal of Biological Chemistry, 2009
- Interaction of Mycobacterium tuberculosis CYP130 with Heterocyclic ArylaminesJournal of Biological Chemistry, 2009
- Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2009
- Reaction ofMycobacterium tuberculosisCytochrome P450 Enzymes with Nitric OxideBiochemistry, 2009
- Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7Nature Protocols, 2008
- Mycobacterial persistence requires the utilization of host cholesterolProceedings of the National Academy of Sciences, 2008